Co-Founder and Managing Partner
Josh Wolfe is a co-founder and managing partner of Lux Capital, focusing on investments in nanotechnology. Before forming Lux Capital, he worked in Salomon Smith Barney's investment banking group, where his experience included a $4 billion hotel merger, and a defense against an unsolicited LBO. Mr. Wolfe has also worked in capital markets while at Merrill Lynch on its financial futures and options/government strategy desk and at Prudential Securities in its municipal finance department. Prior to venturing into the financial world, he conducted and published cutting edge AIDS/immunopathology research in Cell Vision and The Journal of Leukocyte Biology, leading medical/immunology journals. Mr. Wolfe has been an invited guest lecturer and panelist at Harvard, Yale, Wharton, Columbia, University of Virginia, Polytechnic, New York Business Forums, Merrill Lynch, NERASBIC and the Foresight Institute. He is a senior associate of the Foresight Institute for Nanotechnology, the coordinator for the Institute of Molecular Manufacturing's Prize in Computational Nanotechnology, a co-founder of The NanoBusiness Alliance, and a member of the Cognitive Science Society. Mr. Wolfe is the author of The Nanotech Report, and the monthly Forbes/Wolfe Nanotech Report. He graduated with distinction from Cornell University with a BS in economics and finance.